NEW DELHI: The global race to create vaccines against the novel coronavirus has entered a critical stretch, with Pfizer and Moderna releasing very promising final test data that has raised the hopes of nations struggling to combat the pandemic. Pfizer, which reported 95% efficiency, has now applied for early regulatory …
Read More »
Coronavirus Vaccine in India: Bharat Biotech, together with the Indian Council for Medical Research (ICMR) and the National Institute of Virology (NIV), is developing the indigenous coronavirus vaccine Covaxin. Coronavirus vaccine in India: Phase 3 human trials of the indigenous experimental vaccine Covaxin, a candidate for the coronavirus vaccine, are …
Read More »
By: Reuters | November 18, 2020 8:36:37 am A box of the Sinovac Biotech Ltd. SARS-CoV-2 vaccine in Sao Paulo, Brazil, on Wednesday, November 11, 2020. Brazil reversed its decision to suspend trials of the Sinovac coronavirus vaccine amid criticism that the decision was politicized. Photographer: Jonne Roriz / Bloomberg …
Read More »
BENGALURU: The Serum Institute of India, the world’s largest vaccine producer, said Thursday that it has manufactured 40 million doses of AstraZeneca’s potential Covid-19 vaccine and will soon start producing Novavax’s rival vaccine as both seek regulatory approval. While there are no approved Covid-19 vaccines yet and trials are still …
Read More »
Sputnik V, Russia’s experimental COVID-19 vaccine, is 92% effective in protecting people from coronavirus, based on the results of the interim trial, the Russian Direct Investment Fund (RDIF) said on Wednesday. Interim results are based on data from the first 16,000 trial participants who received both injections of the two-dose …
Read More »
Written by Prabha Raghavan, edited by Explained Desk | New Delhi | Updated: November 10, 2020 3:43:25 pm The company’s first interim efficacy analysis indicates that the vaccine may demonstrate efficacy against Covid-19. (Reuters) The American pharmaceutical company Pfizer has launched preliminary data from late-stage human trials of the Covid-19 …
Read More »
According to a plan that was deliberated by a group of experts, state governments would identify buildings that can be used as vaccination booths under the special COVID-19 immunization program that would run in parallel to the Universal Immunization Program (UIP) existing. “Vaccination sites will not be limited to health …
Read More »
The February launch would make Bharat Biotech’s Covid vaccine the first Indian-made vaccine to be launched New Delhi: An Indian government-backed COVID-19 vaccine could be launched in February, months earlier than expected, as late-stage trials begin this month and studies so far have shown it to be safe and effective, …
Read More »
The Serum Institute of India (SII) has joined five candidate vaccines to fight the deadly novel coronavirus, Adar Poonawalla said. Earlier this year, the Pune-based drugmaker signed an agreement with British-Swedish firm AstraZeneca to manufacture its experimental vaccine developed by the University of Oxford. The Oxford COVID-19 vaccine is currently …
Read More »
A safe and effective vaccine against the new coronavirus may be available in India by January 2021, says Adar Poonawalla, executive director (CEO) of the Serum Institute of India. The Pune-based drugmaker teamed up with major British-Swedish drugmaker AstraZeneca to produce the coronavirus vaccine for low- and middle-income countries, developed …
Read More »